← All indications
Neoplasms, Multiple Primary
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
Subtype terms (3)
More specific conditions that are subtypes of Neoplasms, Multiple Primary in the MeSH hierarchy.
- Hamartoma Syndrome, Multiple
6 drugs (4 approved, 2 experimental)
- Multiple Endocrine Neoplasia
6 drugs (5 approved, 1 experimental)
- Tuberous Sclerosis
16 drugs (11 approved, 5 experimental)
Drugs by status
Phase 3 trials (2)
Phase 2 trials (1)
Organizations
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (1)